Director/PDMR Shareholding

RNS Number : 8885W

Kromek Group PLC

14 February 2017

 

14 February 2017

Kromek Group plc

("Kromek" or the "Company" or the "Group")

Director/PDMR Shareholding

Further to the announcement by the Company on 10 February 2017, Sir Peter Williams, the non-Executive Chairman of the Company, has confirmed to the Company that he was allocated, and hence purchased, 14,814 ordinary shares of 1 pence each in the Company ("Ordinary Shares") as part of the open offer announced on 25 January 2017.

The Company has further been informed that on 13 February 2017, Sir Peter Williams bought 35,186 Ordinary Shares at a price of 22.19 pence per Ordinary Share, in the open market.

Following the purchases Sir Peter Williams is beneficially interested in 80,000 Ordinary Shares, representing 0.1 per cent. of the current issued share capital of the Company.

The Company has also been informed that Derek Bulmer, the Chief Financial Officer of the Company, was allocated, and hence purchased, 23,934 Ordinary Shares as part of the open offer. Following the purchase Mr Bulmer is beneficially interested in 63,934 Ordinary Shares, representing 0.1 per cent. of the current issued share capital of the Company.

Finally, further to the announcement made by the Company on 13 February 2017, Jerel Whittingham, a non-Executive Director, has confirmed that he has today purchased 4,440 Ordinary Shares at a price of 21.45 pence per Ordinary Share. Following his purchase Mr Whittingham is beneficially interested in 114,890 Ordinary Shares, representing 0.1 per cent. of the current issued share capital of the Company.

Enquiries

Kromek Group plc	01740 626 060
Arnab Basu, CEO Derek Bulmer, CFO
Cenkos Securities plc	0207 397 8900
Bobbie Hilliam (NOMAD) Harry Pardoe
Luther Pendragon	0207 618 9100
Harry Chathli, Claire Norbury, Alexis Gore

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Sir Peter Williams
2	Reason for the notification
a)	Position/status	Non-Executive Chairman
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Kromek Group plc
b)	LEI	N/a
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary Shares of 1p each
b)	Nature of the transaction	Purchase of Ordinary Shares
c)	Price(s) and volume(s)	Price(s) Volume(s) 20p (Offer price) 14,814
d)	Aggregated information - Aggregated volume - Price	14,814 Ordinary Shares 20p per Ordinary Share
e)	Date of the transaction	13 February 2017
f)	Place of the transaction	N/a

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Sir Peter Williams
2	Reason for the notification
a)	Position/status	Non-Executive Chairman
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Kromek Group plc
b)	LEI	N/a
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary Shares of 1p each
b)	Nature of the transaction	Purchase of Ordinary Shares
c)	Price(s) and volume(s)	Price(s) Volume(s) 22.19p 35,186
d)	Aggregated information - Aggregated volume - Price	35,186 Ordinary Shares 22.19p per Ordinary Share
e)	Date of the transaction	13 February 2017
f)	Place of the transaction	London Stock Exchange

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Derek Bulmer
2	Reason for the notification
a)	Position/status	Chief Financial Officer
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Kromek Group plc
b)	LEI	N/a
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary Shares of 1p each
b)	Nature of the transaction	Purchase of Ordinary Shares
c)	Price(s) and volume(s)	Price(s) Volume(s) 20p (Offer price) 23,934
d)	Aggregated information - Aggregated volume - Price	23,934 Ordinary Shares 20p per Ordinary Share
e)	Date of the transaction	13 February 2017
f)	Place of the transaction	N/a

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Jerel Whittingham
2	Reason for the notification
a)	Position/status	Non-Executive Director
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Kromek Group plc
b)	LEI	N/a
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary Shares of 1p each
b)	Nature of the transaction	Purchase of Ordinary Shares
c)	Price(s) and volume(s)	Price(s) Volume(s) 21.45p 4,440
d)	Aggregated information - Aggregated volume - Price	4,440 Ordinary Shares 21.45p per Ordinary Share
e)	Date of the transaction	14 February 2017
f)	Place of the transaction	London Stock Exchange

About Kromek Group plc

Kromek Group plc is a UK technology company (global HQ in County Durham) and a leading developer of high performance radiation detection products based on cadmium zinc telluride ("CZT").  Using its core CZT technology, Kromek designs, develops and produces x-ray and gamma ray imaging and radiation detection products for the medical, security screening and nuclear markets.

The Group's products provide high resolution information on material composition and structure and are used in multiple applications, ranging from the identification of cancerous tissues to hazardous materials, such as explosives, and the analysis of radioactive materials.

The Group's business model provides a vertically integrated technology offering to customers, from the growth of CZT crystals to finished products or detectors, including software, electronics and application specific integrated circuits ("ASICs").

The Group has operations in the UK and US (California and Pennsylvania), and is selling internationally through a combination of distributors and direct OEM sales.

Currently, the Group has over a hundred full time employees across its global operations. Further information on Kromek Group is available at www.kromek.com.

 

END

 

 

DSHOKQDBOBKDNBD